UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of recent climatic events on the surface water storage of the Tonle Sap Lake

The Science of the total environment, 2018-09, Vol.636, p.1520-1533

2018

Volltextzugriff (PDF)

Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients : a prospective randomised double-blind study

European journal of clinical pharmacology, 2005-07, Vol.61 (5-6), p.347-351

2005

Volltextzugriff (PDF)

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Thrombosis and haemostasis, 1998-06, Vol.79 (6), p.1162-1165

1998

Volltextzugriff (PDF)

Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery

Thrombosis and haemostasis, 1996, Vol.75 (2), p.233-238

1996

Volltextzugriff (PDF)

Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic dose

Thrombosis and haemostasis, 1998-02, Vol.79 (2), p.338-341

1998

Volltextzugriff (PDF)

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

The New England journal of medicine, 1996-03, Vol.334 (11), p.682-687

1996

Volltextzugriff (PDF)

Comparison of a once Daily with a twice Daily Subcutaneous Low Molecular Weight Heparin Regimen in the Treatment of Deep Vein Thrombosis

Thrombosis and haemostasis, 1998-05, Vol.79 (5), p.897-901

1998

Volltextzugriff (PDF)

Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale

Circulation (New York, N.Y.), 1997-11, Vol.96 (10), p.3396-3402

1997

Volltextzugriff (PDF)

Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty : The FACT study

Circulation (New York, N.Y.), 1997-11, Vol.96 (10), p.3396-3402

1997

Volltextzugriff (PDF)

Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis

Archives of internal medicine (1960), 2000-01, Vol.160 (2), p.159

2000

Volltextzugriff (PDF)

Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism : a dose-ranging study

Circulation (New York, N.Y.), 1992-04, Vol.85 (4), p.1380-1389

1992

Volltextzugriff (PDF)

Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216

Thrombosis research, 1990-06, Vol.58 (6), p.555-560

1990

Volltextzugriff (PDF)

Pharmacodynamics of CY 216 in healthy volunteers: inter-individual variations

Fundamental & clinical pharmacology, 1990-01, Vol.4 (1), p.17-23

1990

Volltextzugriff (PDF)

Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group

Thrombosis and haemostasis, 1998-05, Vol.79 (5), p.897

1998

Volltextzugriff (PDF)

Nano-emulsions

Current opinion in colloid & interface science, 2005-10, Vol.10 (3), p.102-110

2005

Volltextzugriff (PDF)

The influence of surfactant mixing ratio on nano-emulsion formation by the pit method

Journal of colloid and interface science, 2005-05, Vol.285 (1), p.388-394

2005

Volltextzugriff (PDF)

Formation and Stability of Nano-Emulsions Prepared Using the Phase Inversion Temperature Method

Langmuir, 2002-01, Vol.18 (1), p.26-30

2002

Volltextzugriff (PDF)

Modulating Thiol pK a Promotes Disulfide Formation at Physiological pH: An Elegant Strategy To Design Disulfide Cross-Linked Hyaluronic Acid Hydrogels

Biomacromolecules, 2019-03, Vol.20 (3), p.1412-1420

2019

Volltextzugriff (PDF)

Phase Behavior and Nano-emulsion Formation by the Phase Inversion Temperature Method

Langmuir, 2004-08, Vol.20 (16), p.6594-6598

2004

Volltextzugriff (PDF)

Deconstructing "Normal" for a More Equitable Post-COVID-19 World

American journal of public health (1971), 2022-04, Vol.112 (4), p.533-533

2022

Volltextzugriff (PDF)

A randomized trial of subcutaneous low molecular weight heparin CY 216 D (fraxiparine R) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism (a dose-ranging study)

Thrombosis research, 1992, Vol.65, p.S114-S114

1992

Volltextzugriff (PDF)

An Old World leaf‐cutting, fungus‐growing ant: A case of convergent evolution

Ecology and evolution, 2023-03, Vol.13 (3), p.e9904-n/a

2023

Volltextzugriff (PDF)

Influence of thromboembolism prophylaxis by low molecular weight heprain CY 216 (Fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216

Thrombosis research, 1990, Vol.58 (6), p.555-560

1990

Volltextzugriff (PDF)

Mesozooplankton affinities in a recovering freshwater estuary

Estuarine, coastal and shelf science, 2016-08, Vol.177, p.47-59

2016

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(64)
Tagungsberichte
(2)

Sprache

Englisch
(59)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(31)
Humans
(21)
Biological And Medical Sciences
(19)
Physical Sciences
(17)
Female
(14)
Medical Sciences
(14)
Male
(13)
Pharmacology. Drug Treatments
(12)
Adult
(11)
Aged
(10)
Middle Aged
(10)
Chemistry
(9)
Blood. Blood Coagulation. Reticuloendothelial System
(8)
Life Sciences
(8)
Marine & Freshwater Biology
(8)
Environmental Sciences
(7)
Oceanography
(7)
Zooplankton
(7)
Cardiovascular System & Cardiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of recent climatic events on the surface water storage of the Tonle Sap Lake

Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients : a prospective randomised double-blind study

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery

Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic dose

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

Comparison of a once Daily with a twice Daily Subcutaneous Low Molecular Weight Heparin Regimen in the Treatment of Deep Vein Thrombosis

Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale

Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty : The FACT study

Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis

Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism : a dose-ranging study

Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216

Pharmacodynamics of CY 216 in healthy volunteers: inter-individual variations

Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group

Nano-emulsions

The influence of surfactant mixing ratio on nano-emulsion formation by the pit method

Formation and Stability of Nano-Emulsions Prepared Using the Phase Inversion Temperature Method

Modulating Thiol pK a Promotes Disulfide Formation at Physiological pH: An Elegant Strategy To Design Disulfide Cross-Linked Hyaluronic Acid Hydrogels

Phase Behavior and Nano-emulsion Formation by the Phase Inversion Temperature Method

Deconstructing "Normal" for a More Equitable Post-COVID-19 World

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

A randomized trial of subcutaneous low molecular weight heparin CY 216 D (fraxiparine R) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism (a dose-ranging study)

An Old World leaf‐cutting, fungus‐growing ant: A case of convergent evolution

Influence of thromboembolism prophylaxis by low molecular weight heprain CY 216 (Fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216

Mesozooplankton affinities in a recovering freshwater estuary

Suchergebnisse filtern